Clinical Value of CA 15-3, Mucin-like Carcinoma-Associated Antigen, Tumor Polypeptide Antigen, and Carcinoembryonic Antigen in Monitoring Early Breast Cancer Patients-Reference-Cited by-同舟云学术

Clinical Value of CA 15-3, Mucin-like Carcinoma-Associated Antigen, Tumor Polypeptide Antigen, and Carcinoembryonic Antigen in Monitoring Early Breast Cancer Patients

Published:1996-10 Issue:5 Volume:19 Page:459-464
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Pectasides D.,Pavlidis N.,Gogou L.,Antoniou F.,Nicolaides C.,Tsikalakis D.,Fountzilas G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference24 articles.

1. Carcinoembryonic antigen in breast cancer patients: Serum levels and disease progress

2. Carcinoembryonic antigen. Clinical and historical aspects

3. A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients

4. CA-15.3, TPA and MCA as markers for breast cancer

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validade dos marcadores tumorais;Revista Brasileira de Cancerologia;2022-09-26

2. A brief procedure for big data analysis of gene expression;Animal Models and Experimental Medicine;2018-09

3. Clinical value of CEA for detection of distant metastases in newly diagnosed breast cancer: comparison with CA 15-3;Annales de biologie clinique;2017-07

4. The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities;Targeted Oncology;2017-03-09

5. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3;Clinica Chimica Acta;2016-10